financetom
Business
financetom
/
Business
/
Cigna misses quarterly profit estimates on higher medical costs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cigna misses quarterly profit estimates on higher medical costs
Jan 30, 2025 3:19 AM

Jan 30 (Reuters) - Cigna ( CI ) forecast annual profit

below Wall Street expectations on Thursday and missed estimates

for the fourth quarter, hurt by higher medical costs for a type

of employer-sponsored healthcare plan.

The plan, called "stop-loss insurance", entails the insurer

covering for employers' self-funded plans when their costs

surpass a certain threshold due to catastrophic or unexpected

medical claims.

The company forecast annual profit per share of at least

$29.50, below analysts estimates of $31.50 per share, according

to data compiled by LSEG.

Cigna ( CI ) manages employer-sponsored healthcare plans, and

unlike its peers, has a smaller presence in the Medicare

Advantage market, where insurers have been grappling with

increased medical costs driven by demand for healthcare services

among older adults.

The health insurer is in the process of selling its

Medicare Advantage business to Health Care Service Corp. The

divestiture, announced last year, is expected to close in the

first quarter of 2025.

For the quarter, its medical care ratio - the percentage of

premiums spent on medical care - came in at 87.9%, up from 82.2%

a year ago. Analysts expected a ratio of 84.84% for the reported

quarter.

"While higher medical costs in our stop-loss product

impacted fourth-quarter earnings, we are taking corrective

actions to address these near-term pressures," said CEO David

Cordani.

On an adjusted basis, Cigna ( CI ) posted fourth-quarter profit of

$6.64 per share, compared with estimates of $7.82.

(Reporting by Sriparna Roy in Bengaluru; Editing by Devika

Syamnath)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Revolution Medicines Insider Sold Shares Worth $446,770, According to a Recent SEC Filing
Revolution Medicines Insider Sold Shares Worth $446,770, According to a Recent SEC Filing
Jun 20, 2024
04:17 PM EDT, 06/20/2024 (MT Newswires) -- Mark A Goldsmith, Director, President and Chief Executive Officer, on June 17, 2024, sold 11,950 shares in Revolution Medicines ( RVMD ) for $446,770. Following the Form 4 filing with the SEC, Goldsmith has control over a total of 838,337 shares of the company, with 311,885 shares held directly and 526,452 controlled indirectly....
Vita Coco Company Insider Sold Shares Worth $1,653,997, According to a Recent SEC Filing
Vita Coco Company Insider Sold Shares Worth $1,653,997, According to a Recent SEC Filing
Jun 20, 2024
04:18 PM EDT, 06/20/2024 (MT Newswires) -- Ira Liran, Director, on June 18, 2024, sold 56,006 shares in Vita Coco Company ( COCO ) for $1,653,997. Following the Form 4 filing with the SEC, Liran has control over a total of 1,578,155 shares of the company, with 634,426 shares held directly and 943,729 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1482981/000148298124000093/xslF345X03/edgardoc.xml Price: 28.10,...
Matson Insider Sold Shares Worth $1,370,476, According to a Recent SEC Filing
Matson Insider Sold Shares Worth $1,370,476, According to a Recent SEC Filing
Jun 20, 2024
04:16 PM EDT, 06/20/2024 (MT Newswires) -- Joel M Wine, Executive Vice President & CFO, on June 18, 2024, sold 11,336 shares in Matson ( MATX ) for $1,370,476. Following the Form 4 filing with the SEC, Wine has control over a total of 160,270 shares of the company, with 160,270 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/3453/000122520824006919/xslF345X03/doc4.xml Price: 123.41, Change:...
--Argan Keeps Quarterly Dividend at $0.30 a Share, Payable July 31 to Shareholders of Record as of July 23
--Argan Keeps Quarterly Dividend at $0.30 a Share, Payable July 31 to Shareholders of Record as of July 23
Jun 20, 2024
04:20 PM EDT, 06/20/2024 (MT Newswires) -- Price: 75.39, Change: +0.06, Percent Change: +0.08 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved